Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

LINAC-based radiosurgery effectively reduces seizures but causes significant side effects (opens in a new tab)

news-medical.net · 2026-10-27

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

One claim goes further than the study. 3 other points were not covered by the paper.

  • 1 supported
  • 1 overstated
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

One claim overstates the study. One of five checks out. Three claims the study doesn't address.

  • 1 supported
  • 1 overstated
  • 3 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5OverstatedLINAC-based radiosurgery decreased seizure frequency by 75.6% and reduced auras by 60.0% at 24 months among patients who had auras before surgery, but it did not completely stop epilepsy.View evidenceHide evidence

As stated75.6% seizure reduction; 60.0% aura reduction

Why this verdict

The numerical findings are supported as observed outcomes: median monthly seizure frequency fell by 75.6%, aura frequency among those with preoperative auras fell by 60%, and no participant achieved seizure freedom. But the claim is framed causally in a headline-prominent way—'LINAC-based radiosurgery decreased' these outcomes—despite the paper being an uncontrolled, small case series. The headline framing therefore outruns what the observational evidence can establish, even though the underlying observed reductions are reported.

1

Study evidence

No participant achieved seizure freedom (Engel Class I / ILAE Class 1) at 24 months post-radiosurgery.0/7 (0%)

“A prospective, single-center, exploratory pilot case series was conducted from March 1, 2017, to March 1, 2020”
2

Study evidence

Visual field deficits occurred in 3 of 7 patients (42.8%).3/7 (42.8%)

“Adverse events included visual field deficits in three patients (42.8%), psychiatric complications in two (28.6%), and clinically significant memory decline in one patient”
Claim 2 of 5Not coveredThe study included seven adult patients with drug-resistant unilateral MTLE who underwent LINAC-based radiosurgery and were followed clinically, electroencephalographically, and with neuroimaging for up to 24 months.View evidenceHide evidence

As statedseven patients; 24-month follow-up

Why this verdict

The profile supports seven adult patients with drug-resistant unilateral MTLE, LINAC radiosurgery, and 24-month follow-up. However, the specific statement that follow-up was clinical, electroencephalographic, and neuroimaging-based is not established in the abstract-level profile supplied here.

1

Study evidence

No participant achieved seizure freedom (Engel Class I / ILAE Class 1) at 24 months post-radiosurgery.0/7 (0%)

“A prospective, single-center, exploratory pilot case series was conducted from March 1, 2017, to March 1, 2020”
2

Study evidence

Visual field deficits occurred in 3 of 7 patients (42.8%).3/7 (42.8%)

“Adverse events included visual field deficits in three patients (42.8%), psychiatric complications in two (28.6%), and clinically significant memory decline in one patient”
Claim 3 of 5Not coveredThe treatment was associated with several adverse events, including visual field deficits in three patients, recent memory impairment in one patient, new auras in three patients who previously had none, psychotic episodes requiring intervention in two patients, and headaches.View evidenceHide evidence

As statedthree VFDs; one memory impairment; three new auras; two psychotic episodes

Why this verdict

The abstract-level profile supports an association with adverse outcomes including visual field deficits in 3/7, psychiatric complications in 2/7, clinically significant memory decline in one patient, and de novo auras in three previously aura-free patients. However, the more specific wording that the psychiatric events were 'psychotic episodes requiring intervention' and the inclusion of headaches are not verified in the supplied abstract-level profile.

1

Study evidence

Visual field deficits occurred in 3 of 7 patients (42.8%).3/7 (42.8%)

“Adverse events included visual field deficits in three patients (42.8%), psychiatric complications in two (28.6%), and clinically significant memory decline in one patient”
Claim 4 of 5Not coveredThe authors say LINAC radiosurgery may be an effective alternative to conventional ATL for drug-resistant MTLE, but controlled clinical trials with structural and functional neuroimaging biomarkers are warranted.View evidenceHide evidence

Why this verdict

The profile supports a cautious interpretation: clinically meaningful seizure reduction in a small case series, no seizure freedom, delayed adverse events, and the need for larger/longer and more rigorous study. But the exact author statement that LINAC radiosurgery 'may be an effective alternative to conventional ATL' and that controlled trials with structural and functional neuroimaging biomarkers are warranted is not fully verifiable from the supplied abstract-level profile.

1

Study evidence

No participant achieved seizure freedom (Engel Class I / ILAE Class 1) at 24 months post-radiosurgery.0/7 (0%)

“A prospective, single-center, exploratory pilot case series was conducted from March 1, 2017, to March 1, 2020”
2

Study evidence

Visual field deficits occurred in 3 of 7 patients (42.8%).3/7 (42.8%)

“Adverse events included visual field deficits in three patients (42.8%), psychiatric complications in two (28.6%), and clinically significant memory decline in one patient”
Claim 5 of 5SupportedMexican researchers examined the therapeutic efficacy of non-invasive LINAC-based radiosurgery in mesial temporal lobe epilepsy (MTLE), which the story presents as an alternative for patients who are not candidates for anterior temporal lobectomy.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that the paper evaluated LINAC-based stereotactic radiosurgery for adults with drug-resistant unilateral MTLE as a nonresective intervention, in the context that some MTLE patients may be unsuitable for anterior temporal lobectomy. The claim is framed as what the researchers examined, rather than as proof of efficacy.

1

Study evidence

No participant achieved seizure freedom (Engel Class I / ILAE Class 1) at 24 months post-radiosurgery.0/7 (0%)

“A prospective, single-center, exploratory pilot case series was conducted from March 1, 2017, to March 1, 2020”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Memory decline occurred in one patient with pre-existing cognitive impairment, complicating attribution to radiosurgery.

    The story reports memory impairment as an adverse effect but does not mention that the affected patient had pre-existing cognitive impairment, an interpretation-relevant limitation for attributing the decline to treatment.

    From Prospective single-center pilot case series

4 things the story did carry across
  • The paper is a prospective, single-center exploratory pilot case series of seven adults with drug-resistant unilateral MTLE treated with hippocampal-targeted LINAC stereotactic radiosurgery and followed for 24 months.
  • Observed efficacy outcomes included no seizure freedom at 24 months, a median 75.6% reduction in monthly seizure frequency, and a median 60% aura reduction among patients with preoperative auras.
  • The uncontrolled case-series design, very small sample size, and lack of randomization/blinding/control group limit causal inference and generalizability.
  • Safety findings included visual field deficits, psychiatric complications, clinically significant memory decline in one patient with pre-existing impairment, and de novo auras in previously aura-free patients.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoEvaluate the anticonvulsant efficacy of LINAC-based stereotactic radiosurgery targeting the hippocampal head/anterior body in adults with drug-resistant unilateral mesial temporal lobe epilepsy (MTLE) over 24 months.Prospective single-center exploratory pilot case seriesExpand

In plain English

Prospective single-center exploratory pilot case series (n=7 adults aged 18–65) of LINAC-based stereotactic radiosurgery targeting the hippocampal head and anterior body (22 Gy prescribed, normalized to the 50% isodose line; V100 ≥ 90%; dose gradient < 10%) for drug-resistant unilateral mesial temporal lobe epilepsy. Primary outcome (seizure freedom, Engel I / ILAE 1) at 24 months was not achieved by any participant. Median monthly seizure frequency fell from 12 to 3.5 at 24 months (median reduction 75.6%; Friedman χ2 = 14.62, p = 0.006). Kaplan–Meier analysis indicated 71.4% of patients maintained a ≥50% seizure reduction through 24 months. Adverse events included visual field deficits (3/7), psychiatric complications (2/7), and clinically significant memory decline in one patient with preexisting impairment; de novo auras developed in three previously aura-free patients.

Key findings

  • No participant achieved seizure freedom (Engel Class I / ILAE Class 1) at 24 months post-radiosurgery.0/7 (0%)
  • Median monthly seizure frequency decreased from 12 at baseline to 3.5 at 24 months (median reduction 75.6%).Median reduction 75.6%; Friedman χ2 = 14.62, p = 0.006
“A prospective, single-center, exploratory pilot case series was conducted from March 1, 2017, to March 1, 2020”
What this piece can’t prove
  • Very small sample size (n = 7) and single-center exploratory case series design.
  • No control group, randomization, or blinding — limits causal inference about treatment effect.
  • Findings may not generalize beyond selected patients meeting inclusion criteria (adult unilateral MTLE) and the specific radiosurgery planning parameters used.
  • Adverse-event attribution and long-term safety require larger cohorts and longer follow-up; delayed adverse events were reported.
2human in vivoCharacterize safety/adverse events and cognitive/psychiatric outcomes following hippocampal-targeted LINAC radiosurgery in this MTLE case series.Prospective single-center pilot case seriesExpand

In plain English

In a prospective, single-center case series of 7 patients with drug-resistant unilateral mesial temporal lobe epilepsy treated with LINAC-based stereotactic radiosurgery targeting the hippocampal head and anterior body (22 Gy normalized to the 50% isodose line; V100 ≥ 90%), clinically meaningful seizure reduction was reported but no patients achieved seizure freedom. Adverse events over 24 months included visual field deficits (3/7), psychiatric complications (2/7), and clinically significant memory decline in one patient with pre-existing cognitive impairment; aura outcomes showed a median 60% reduction among those with preoperative auras while three previously aura-free patients developed de novo auras. Reporting in the abstract lacks detail on adverse-event grading, timing, and the methods used for neurocognitive and psychiatric assessment.

Key findings

  • Visual field deficits occurred in 3 of 7 patients (42.8%).3/7 (42.8%)
  • Psychiatric complications were reported in 2 of 7 patients (28.6%).2/7 (28.6%)
“Adverse events included visual field deficits in three patients (42.8%), psychiatric complications in two (28.6%), and clinically significant memory decline in one patient”
What this piece can’t prove
  • Very small sample size (n=7) from a single center limits generalizability and precision of event rate estimates.
  • Observational, uncontrolled case-series design precludes causal inference about treatment-related harms.
  • Abstract lacks detail on adverse-event ascertainment, grading/scales, and timing; unclear whether standardized neuropsychological or psychiatric instruments were used.
  • Baseline neurocognitive status and extent of pre-existing impairments are not fully described; this complicates attribution of memory decline to the intervention.

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 36 candidate papers

Candidate

Author response for "Political and Content Drivers of Social Media Impact in Spanish General Elections: A Twelve-Year Analysis from Leading Candidates on Twitter"

2026 · Crossref

Source (opens in a new tab)

And 30 more candidates considered.